Portal de Periódicos da CAPES

Effect of vitamin C supplement on antipyrine disposition in man.

1977; Wiley; Volume: 4; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2125.1977.tb00701.x

1365-2125

JB Houston,

Vitamin K Research Studies

British Journal of Clinical PharmacologyVolume 4, Issue 2 p. 236-239 Free Access Effect of vitamin C supplement on antipyrine disposition in man. JB Houston, JB HoustonSearch for more papers by this author JB Houston, JB HoustonSearch for more papers by this author First published: April 1977 https://doi.org/10.1111/j.1365-2125.1977.tb00701.xCitations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References ANDREASEN, P.B. & VESELL, E.S. (1975). Comparison of plasma levels of antipyrine, tolbutamide and warfarin after oral and intravenous administration. Clin. Pharmac. Ther., 16, 1059– 1065. BRODIE, B.B. & AXELROD, J. (1950). The fate of antipyrine in man. J. Pharmac. exp. Ther., 98, 97– 104. BRANCH, R.A., SHAND, D.G., WILKINSON, G.R. & NIES, A.S. (1974). Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in monkey. J. clin. Invest., 53, 1101– 1107. CHANG, R.L., WOOD, A.W., DIXON, W.R., CONNEY, A.H. ANDERSON, W.E., EISEMAN, J. & ALVARES, A.P. (1976). Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Clin. Pharmac. Ther., 20, 219– 226. DEGKWITZ, E. & KIM, K.S. (1973). Comparative studies on the influence of 1-ascorbate, d-arabino-ascorbate and 5-oxo-d-gluconate on the amounts of cytochromes P-450 and b5 in liver microsomes of guinea pigs. Hoppe-Seyler's Z. Physiol. Chem., 354, 555– 561. EICHELBAUM, M. SCHOMERUS, M., SPANNBRUCKER, N. & ZIETZ, E. (1976). The physiological disposition of antipyrine in man. Naunyn-Schmiedeberg's Arch. Pharmac., 293, Suppl., R63. FEETAM, C.L., LEACH, R.H. & MEYNELL, M.J. (1975). Lack of clinically important interaction between warfarin and ascorbic acid. Toxicol. appl. Pharmac., 31, 544– 547. FRASER, H.S., MUCKLOW, J.C., MURRAY, S. & DAVIES, D.S. (1976). Assessment of antipyrine kinetics by measurement in saliva. Br. J. clin. Pharmac., 3, 321– 325. HOUSTON, J.B. & LEVY, G. (1975). Modification of drug biotransformation by vitamin C in man. Nature, Lond., 255, 78– 79. HOUSTON, J.B. & LEVY, G. (1976a). Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid. J. pharm. Sci., 65, 1218– 1221. HOUSTON, J.B. & LEVY, G. (1976b). Effect of route of administration on competitive drug biotransformation interactions: salicylamide-ascorbic acid interaction in rats. J. Pharmac. exp. Ther., 198, 284– 294. HOUSTON, J.B. WILKENS, H.J. & LEVY, G. (1976). Potentiation of isoproterenol effect by ascorbic acid. Res Comm. Chem. Path. Pharmac., 14, 643– 650. KELLERMANN, G., LUYTEN-KELLERMANN, M., HORNING, M. & STAFFORD, M. (1976). Elimination of antipyrine and benzo[a] pyrene metabolism in cultured human lymphocytes. Clin. Pharmac. Ther., 20, 72– 80. LINDGREN, S. COLLSTE, P., NORLANDER, B. & SJOQVIST, F. (1974). Gas chromatographic assessment of the reproducibility of phenazone half-life in young healthy volunteers. Eur. J. clin. Pharmac., 7, 381– 385. O'MALLEY, K., STEVENSON, I.H. & WEST, M. (1975). Effect of fenfluramine on disposition and rate of antipyrine elimination. Pharmacology, 13, 12– 19. PAGLIARO, L.A. & BENET, L.Z. (1975). Critical compilation of terminal half-lives, percent excreted unchanged and changes of half-life in renal and hepatic dysfunction for studies in humans with references. J. Pharmacokinetics Biopharm., 3, 333– 383. SATO, P.H. & ZANNONI, V.G. (1974). Stimulation of drug metabolism by ascorbic acid in weanling guinea pigs. Biochem. Pharmac., 23, 3121– 3128. SATO, P.H. & ZANNONI, V.G. (1976). Ascorbic acid and hepatic drug metabolism J. Pharmac, exp. Ther., 198, 295– 307. VAN BOXTEL, C.J., WILSON, J.T., LINDGREN, S. & SJOQVIST, F. (1976). Comparison of half-life of antipyrine in plasma, whole blood and saliva of man. Eur. J. clin. Pharmac., 9, 327– 332. VESELL, E.S. PASSANANTI G.T., GLENWRIGHT, P.A. & DVORCHIK, B.H. (1975). Studies on the disposition of antipyrine and phenacetin using plasma, saliva and urine. Clin. Pharmac. Ther., 18, 259– 272. VESTAL, R.E. NORRIS, A.H., TOBIN, J.D., COHEN, B.H. SHOCK, N.W. & ANDRES, R. (1975). Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin. Pharmac. Ther., 18, 425– 432. WELCH, R.M. DeANGELIS, R.L. WINGFIELD, M. & FARMER, T.W. (1975). Elimination of antipyrine from saliva as a measure of metabolism in man, Clin. Pharmac. Ther., 18, 249– 258. WILSON, J.T., VAN BOXTEL, C.J., ALVAN, G. & SJOQVIST, F. (1976). Failure of vitamin C to affect pharmacokinetic profile of antipyrine in man. J. clin. Pharmac., 16, 265– 270. Citing Literature Volume4, Issue2April 1977Pages 236-239 ReferencesRelatedInformation